In a major development, the drug regulator in the United States (US) have allowed the inoculation of children as young as 12 years with Pfizer's two-dose mRNA COVID-19 vaccine, reports Livemint.
After the clearance for emergency use from US Food and Drug Administration expanded, the Pfizer Covid-19 vaccine can now be used in inoculation of those aged between 12-15 years in US.
The US' Food and Drug Administration has declared that the said vaccine is safe and offers strong protection for younger teenagers based on testing of more than 2,000 US volunteers aged between 12 and 15 years. It added that the study found no cases of COVID-19 among fully vaccinated adolescents compared to 18 among kids given dummy shots.
FDA said that the researchers also found that the kids developed higher levels of virus-fighting antibodies than earlier studies measured in young adults.
The development gains significance because most COVID-19 vaccines globally have only been authorised for adults. Also, it should be noted that Canada has already allowed the use of Pfizer's COVID-19 vaccine for those aged 12 years and above.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.